ROCKET PHARMACEUTICALS INC (RCKT) Stock Analyst Ratings
NASDAQ:RCKT - Nasdaq - US77313F1066 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to RCKT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.61. This target is 478% above the current price.
RCKT was analyzed by 24 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about RCKT.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
RCKT was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-17 | UBS | Maintains | Buy -> Buy |
| 2025-06-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-28 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-05-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-28 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-28 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-05-28 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-28 | Jefferies | Downgrade | Buy -> Hold |
| 2025-05-27 | Needham | Downgrade | Buy -> Hold |
| 2025-05-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-05-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-12 | BMO Capital | Initiate | Outperform |
| 2025-03-03 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-03-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-28 | Needham | Maintains | Buy -> Buy |
| 2024-12-18 | Jefferies | Initiate | Buy |
| 2024-11-19 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-11-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-19 | Needham | Reiterate | Buy -> Buy |
| 2024-11-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-18 | Chardan Capital | Maintains | Buy -> Buy |